US-based surgical implant company RTI Surgical has announced the full market launch of its Streamline OCT system, designed to promote fusion of the occipto-cervico-thoracic spine (or occiput-T3).
RTI Surgical has designed the Streamline OCT system for use in the treatment of spinal stenosis, tumors, degenerative disc disease and spondylolisthesis, among others.
By offering a broad range of implants, the Streamline OCT system allows a rigid construct to be created from occiput toT3.
RTI Surgical president and CEO Brian K Hutchison noted that the Streamline OCT system is another exciting addition to the company’s spine portfolio.
"We are proud to have a system that offers a range of implants where surgeons can tailor treatment for their patients and provide a more streamlined surgical experience," Hutchison added.
The Streamline OCT system features a high-angle pedicle screw that is capable of achieving 60 degrees of angulation in any direction, providing greater intraoperative flexibility and options for screw placement. In addition, the system offers a unique occipital plate design that reduces the need for extreme rod bends.
Premier Orthopaedics and Sports Medicine, Bloomingfield, board-certified orthopedic surgeon and a Fellow with the American Academy of Orthopaedic Surgeons Dr Anthony Lapinsky is one of the design surgeons of the Streamline OCT system.
In March 2014, the Streamline OCT system obtained 510(k) approval from the US Food and Drug Administration (FDA).